KalVista Pharmaceuticals, Inc.
NasdaqGM:KALV
$ 11.92
$0.00 (0.00%)
$ 11.92
$0.00 (0.00%)
End-of-day quote: 05/18/2024

KALV - KalVista Pharmaceuticals Stock Prediction 2025 - 2030

7 years of reliable KalVista Pharmaceuticals stock forecast. The Wall Street analysts predict Buy for KALV. See at a glance whether NasdaqGM:KALV will rise in the future.

$0.00
Forecast 2023
$0.00 $13.18
Forecast 2025
$22.40
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$0.00 $13.18
Forecast 2030
$22.40
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.92
Price-to-book Ratio
4.66
Market Cap
0.48B
TEV
0.50 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$20.80

KalVista Pharmaceuticals Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

KalVista Pharmaceuticals Stock Forecast 2023

$35.00

In the last five quarters, KalVista Pharmaceuticals’s Price Target has risen from $15.24 to $20.80 - a 36.48% increase. Five analysts predict that KalVista Pharmaceuticals’s share price will increase in the coming year, reaching $35.00. This would represent an increase of 68.27%.

193.62%
193.62
Last update: 05/19/2024

Highest Price Target $39.00

Average Price Target $35.00

Lowest Price Target $20.00

KalVista Pharmaceuticals Stock Forecast 2025

KalVista Pharmaceuticals Stock Predictions 2030

KalVista Pharmaceuticals Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of $21.84. An increase of 83.19% compared to the previous month's estimate.

KalVista Pharmaceuticals Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of $22.02. An increase of 84.77% compared to the previous month's estimate.

KalVista Pharmaceuticals Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of $22.21. An increase of 86.35% compared to the previous month's estimate.

KalVista Pharmaceuticals Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of $22.40. An increase of 87.92% compared to the previous month's estimate.

KalVista Pharmaceuticals Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of $22.61. An increase of 89.68% compared to the previous month's estimate.

KalVista Pharmaceuticals Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of $22.82. An increase of 91.43% compared to the previous month's estimate.

KalVista Pharmaceuticals Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of $23.03. An increase of 93.18% compared to the previous month's estimate.

KalVista Pharmaceuticals Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of $23.24. An increase of 94.93% compared to the previous month's estimate.

KalVista Pharmaceuticals Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of $23.44. An increase of 96.68% compared to the previous month's estimate.

KalVista Pharmaceuticals Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of $23.65. An increase of 98.44% compared to the previous month's estimate.

KalVista Pharmaceuticals Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of $23.86. An increase of 100.19% compared to the previous month's estimate.

KalVista Pharmaceuticals Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of $24.07. An increase of 101.94% compared to the previous month's estimate.

P/E
0.00
Beta
0.92
Price-to-book Ratio
4.66
Market Cap
0.48B
TEV
0.50 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$20.80

KalVista Pharmaceuticals Analyst Ratings Frequently Asked Questions

Who are the analysts watching KalVista Pharmaceuticals, Inc.?

The following analysts have recently covered KalVista Pharmaceuticals:

Cantor Fitzgerald & Co.
H.C. Wainwright & Co.
Jefferies LLC
Leerink Partners LLC
Needham & Company
Stifel
Marktfeld
(This information refers to the last 90 days.)

Who are the sell-side analysts watching KalVista Pharmaceuticals, Inc.?

The following sell-side analysts have recently covered KalVista Pharmaceuticals:

Duncan, Charles Cliff
Fein, Andrew S.
Raycroft, Maurice Thomas
Schwartz, Joseph Patrick
Belanger, Serge D.
Matteis, Paul Andrew
Paraskevopoulos, Michail
(This information refers to the last 90 days.)